In our preliminary experiments, we used three different doses of rh-endostatin, including 20 mg/kg, 10 mg/kg and 5 mg/kg in the treatment of A549 lung cancer bearing mice and did not find any significant difference in the antitumor effect among the three doses. The gene discussed is COL18A1; the disease is lung carcinoma.